S. Akbaş Et Al. , "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2," 17th International Child Neurology Congress , Antalya, Turkey, 2022
Akbaş, S. Et Al. 2022. Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2. 17th International Child Neurology Congress , (Antalya, Turkey).
Akbaş, S., Hırfanoğlu, T., Börcek, A. Ö., Atalay, T., Endürlük, S., Karaca, N. B., ... Cankurt, İ.(2022). Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2 . 17th International Child Neurology Congress, Antalya, Turkey
Akbaş, Salih Et Al. "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2," 17th International Child Neurology Congress, Antalya, Turkey, 2022
Akbaş, Salih Et Al. "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2." 17th International Child Neurology Congress , Antalya, Turkey, 2022
Akbaş, S. Et Al. (2022) . "Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2." 17th International Child Neurology Congress , Antalya, Turkey.
@conferencepaper{conferencepaper, author={Salih Akbaş Et Al. }, title={Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2}, congress name={17th International Child Neurology Congress}, city={Antalya}, country={Turkey}, year={2022}}